Beta Bionics vs Butterfly Network
Beta Bionics and Butterfly Network are similar in size: $100m and $97.6m of revenue in their latest fiscal years. Beta Bionics grew faster (53.9% against 19.0%). Beta Bionics kept more of each dollar of sales as profit: a net margin of -73.0% against -79.0%. Beta Bionics carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Beta BionicsBBNX, 2025 | Butterfly NetworkBFLY, 2025 |
|---|---|---|
| Revenue | $100m | $97.6m |
| Revenue growth | 53.9% | 19.0% |
| Net income | −$73.2m | −$77.1m |
| Operating margin | -71.5% | -88.5% |
| Net margin | -73.0% | -79.0% |
| Return on equity | — | -42.2% |
| Free cash flow | −$56.2m | −$16.0m |
| Cash | $31.6m | $150m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 420 | 220 |
| Market value | $817m | $1.69bn |
| Price vs our value range | — | — |
| Moat score | — | 18 (Weak) |
| Insider trades, 12 months | 0 buys, 52 sales | 9 buys, 76 sales |